
zzso is a zzso zzso agent which is now an established part of therapy in patients with immune zzso It is effective against zzso zzso zzso when used orally once daily either as treatment or secondary prophylaxis in patients with AIDS or as treatment or primary prophylaxis in zzso associated with cancer zzso zzso also resolves symptoms in up to zzso of patients with zzso meningitis and zzso However, in this infection its efficacy as treatment relative to that of zzso B is zzso and its major role is as the drug of choice for maintenance therapy following zzso B zzso In this regard, zzso has been proven superior to zzso B and to zzso 200 zzso Comparisons with other drugs used for the treatment of zzso zzso in patients with AIDS show zzso to be superior to zzso similar to zzso and at least as effective as zzso and zzso it was more so than the latter zzso in 1 zzso In patients undergoing chemotherapy or bone zzso zzso zzso as primary prophylaxis has produced greater clinical benefit than a zzso zzso The zzso of adverse events appears to be somewhat higher in patients with AIDS compared with zzso zzso but the qualitative pattern of events is zzso The most frequent events are gastrointestinal complaints, headache and skin zzso rare zzso skin reactions and isolated instances of clinically overt zzso dysfunction have occurred in patients with zzso zzso yet to be clarified include: the use of zzso in children with zzso in whom results have been zzso its efficacy against other zzso infections encountered in zzso zzso whether the drug influences zzso as has been suggested by one zzso trial in patients undergoing bone zzso zzso and the appropriateness of its potential for use as primary prophylaxis against zzso meningitis in patients with zzso where it shows efficacy but there is concern over increasing risk of development of secondary zzso Notwithstanding these undefined aspects of its clinical profile, zzso is now confirmed as an important zzso drug in the management of zzso infections in patients with immune zzso In patients with AIDS it is the present drug of choice as maintenance therapy against zzso meningitis and is a preferred agent for secondary prophylaxis against zzso zzso it is also a zzso agent for primary prophylaxis in patients at risk because of zzso associated with chemotherapy or bone zzso transplantation zzso 

